Biotech

All Articles

Former Seagen chief executive officer reveals brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer last year for a massive...

Ironwood creates further purpose $1B GI medication with brand new subgroup records

.On the heels of a stage 3 gain that neglected to wow real estate investors, Ironwood Pharmaceutical...

Novartis inks $150M bargain for autoimmune molecular glue

.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is actually enjoying after autho...

Jade takes director crew along with Chinook vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Septerna goes social with upsized offering of $288M

.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sound...

AbbVie brings in Richter wealthier, paying out $25M to make up invention deal

.AbbVie has gone back to the source of its own antipsychotic giant Vraylar looking for another runaw...

GenSight gets in final weeks of money runway as income flow slips by of reach

.GenSight Biologics is actually weeks away from running out of loan. Once again. The biotech simply ...

AZ licenses thrown out unusual illness medicine to Monopar Rehabs

.Monopar Rehabs is actually recuperating a medication from the scrap heap of AstraZeneca's uncommon ...

Arcus' brand-new HIF-2a data in kidney cancer cells hint at prospective upper hand over Merck's Welireg, analysts point out

.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one group of professiona...

Roche wagers as much as $1B to grow Dyno genetics treatment delivery contract

.After forming a genetics treatment alliance along with Dyno Rehabs in 2020, Roche is actually back ...